842 related articles for article (PubMed ID: 16287793)
21. [Clinical characteristics of health screen examinees with nonalcoholic fatty liver and normal liver function test].
Lee SY; Kim SK; Kwon CI; Kim MJ; Kang MS; Ko KH; Hong SP; Hwang SG; Park PW; Rim KS
Korean J Gastroenterol; 2008 Sep; 52(3):161-70. PubMed ID: 19077512
[TBL] [Abstract][Full Text] [Related]
22. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.
Kim HJ; Kim HJ; Lee KE; Kim DJ; Kim SK; Ahn CW; Lim SK; Kim KR; Lee HC; Huh KB; Cha BS
Arch Intern Med; 2004 Oct; 164(19):2169-75. PubMed ID: 15505132
[TBL] [Abstract][Full Text] [Related]
23. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.
Grattagliano I; Ubaldi E; Napoli L; Marulli CF; Nebiacolombo C; Cottone C; Portincasa P
Ann Hepatol; 2013; 12(1):70-7. PubMed ID: 23293196
[TBL] [Abstract][Full Text] [Related]
24. Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses.
Kim CW; Yun KE; Jung HS; Chang Y; Choi ES; Kwon MJ; Lee EH; Woo EJ; Kim NH; Shin H; Ryu S
J Hepatol; 2013 Aug; 59(2):351-7. PubMed ID: 23578884
[TBL] [Abstract][Full Text] [Related]
25. Gender differences in the association of non-alcoholic fatty liver disease and metabolic syndrome with erosive oesophagitis: a cross-sectional study in a Taiwanese population.
Hung WC; Wu JS; Sun ZJ; Lu FH; Yang YC; Chang CJ
BMJ Open; 2016 Nov; 6(11):e013106. PubMed ID: 27852719
[TBL] [Abstract][Full Text] [Related]
26. [Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?].
Graffigna MN; Belli SH; de Larrañaga G; Fainboim H; Estepo C; Peres S; García N; Levalle O
Acta Gastroenterol Latinoam; 2009 Mar; 39(1):30-7. PubMed ID: 19408737
[TBL] [Abstract][Full Text] [Related]
27. Relation of nonalcoholic fatty liver disease to the metabolic syndrome: the Multi-Ethnic Study of Atherosclerosis.
Zeb I; Katz R; Nasir K; Ding J; Rezaeian P; Budoff MJ
J Cardiovasc Comput Tomogr; 2013; 7(5):311-8. PubMed ID: 24268118
[TBL] [Abstract][Full Text] [Related]
28. Alcohol consumption appears to protect against non-alcoholic fatty liver disease.
Moriya A; Iwasaki Y; Ohguchi S; Kayashima E; Mitsumune T; Taniguchi H; Ikeda F; Shiratori Y; Yamamoto K
Aliment Pharmacol Ther; 2011 Feb; 33(3):378-88. PubMed ID: 21118396
[TBL] [Abstract][Full Text] [Related]
29. [Frequency and clinical, biochemical and histological characteristics of nonalcoholic fatty liver disease in patients with gallstone disease].
Roesch-Dietlen F; Pérez-Morales A; Melo-Santisteban G; Díaz-Blanco F; Martínez-Fernández S; Martínez JA; Cid-Juárez S
Cir Cir; 2008; 76(1):37-42. PubMed ID: 18492418
[TBL] [Abstract][Full Text] [Related]
30. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai].
Fang JG; Zhu J; Li XJ; Li R; Dai F; Song XM; Chen L; Li F; Chen SY
Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):83-8. PubMed ID: 15727689
[TBL] [Abstract][Full Text] [Related]
31. BMI history and risk of incident fatty liver: a population-based large-scale cohort study.
Hashimoto Y; Hamaguchi M; Fukuda T; Nakamura N; Ohbora A; Kojima T; Fukui M
Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1188-93. PubMed ID: 27347789
[TBL] [Abstract][Full Text] [Related]
32. Biphasic effect of alcohol intake on the development of fatty liver disease.
Takahashi H; Ono M; Hyogo H; Tsuji C; Kitajima Y; Ono N; Eguchi T; Fujimoto K; Chayama K; Saibara T; Anzai K; Eguchi Y
J Gastroenterol; 2015 Nov; 50(11):1114-23. PubMed ID: 25733100
[TBL] [Abstract][Full Text] [Related]
33. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
34. Roles of alcohol consumption in fatty liver: a longitudinal study.
Moriya A; Iwasaki Y; Ohguchi S; Kayashima E; Mitsumune T; Taniguchi H; Ando M; Yamamoto K
J Hepatol; 2015 Apr; 62(4):921-7. PubMed ID: 25433160
[TBL] [Abstract][Full Text] [Related]
35. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
Dietrich P; Hellerbrand C
Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
[TBL] [Abstract][Full Text] [Related]
36. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
[TBL] [Abstract][Full Text] [Related]
37. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease.
Angelico F; Del Ben M; Conti R; Francioso S; Feole K; Fiorello S; Cavallo MG; Zalunardo B; Lirussi F; Alessandri C; Violi F
J Clin Endocrinol Metab; 2005 Mar; 90(3):1578-82. PubMed ID: 15598693
[TBL] [Abstract][Full Text] [Related]
38. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study.
van der Voort EA; Koehler EM; Dowlatshahi EA; Hofman A; Stricker BH; Janssen HL; Schouten JN; Nijsten T
J Am Acad Dermatol; 2014 Mar; 70(3):517-24. PubMed ID: 24373781
[TBL] [Abstract][Full Text] [Related]
39. Nonalcoholic Fatty Liver Disease and Continuous Metabolic Syndrome in Adolescents with Overweight/Obesity.
Ferreira S; Mendes J; Couto D; Ferreira D; Rêgo C
Acta Med Port; 2024 Mar; 37(3):177-186. PubMed ID: 38330918
[TBL] [Abstract][Full Text] [Related]
40. Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men.
Ryu S; Chang Y; Kim SG; Cho J; Guallar E
Metabolism; 2011 Jun; 60(6):860-6. PubMed ID: 20863537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
